Novelion Therapeutics Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Vancouver British Columbia Canada (1981)
Status: Acquired by Amryt Research Limited (2019)

Organization Overview

First Clinical Trial
2000
NCT00007969
First Marketed Drug
2012
lomitapide (juxtapid)
First NDA Approval
2012
lomitapide (juxtapid)
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aegerion | AEGERION | Aegerion Pharmaceuticals | Aegerion Pharmaceuticals, Inc. | QLT | QLT Inc | QLT Inc. | QLT Phototherapeutics | QLT USA, Inc | QLT USA, Inc.